Statera Biopharma Stock Performance

Statera Biopharma Relative Risk vs. Return Landscape

If you would invest  0.01  in Statera Biopharma on November 5, 2025 and sell it today you would earn a total of  0.00  from holding Statera Biopharma or generate 0.0% return on investment over 90 days. Statera Biopharma is currently generating 10.4167% in daily expected returns and assumes 52.4724% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Statera, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Statera Biopharma is expected to generate 69.16 times more return on investment than the market. However, the company is 69.16 times more volatile than its market benchmark. It trades about 0.2 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.1 per unit of risk.

Statera Biopharma Target Price Odds to finish over Current Price

Given the investment horizon of 90 days the pink sheet has the beta coefficient of 9.11 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Statera Biopharma will likely underperform. In addition to that Statera Biopharma has an alpha of 8.2855, implying that it can generate a 8.29 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Statera Biopharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Statera Biopharma. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.00 0.000091 50.01 Details

Intrinsic Valuation Low Real High 0.00 0.000081 50.01 Details

Naive Forecast Low Next High 0.000004 0.0002 52.47 Details

Bollinger Band Projection (param) Lower Middle Band Upper 0.0002 0.0002 0.0002 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Statera Biopharma. Your research has to be compared to or analyzed against Statera Biopharma's peers to derive any actionable benefits. When done correctly, Statera Biopharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Statera Biopharma.

Statera Biopharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Statera Biopharma is not an exception. The market had few large corrections towards the Statera Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Statera Biopharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Statera Biopharma within the framework of very fundamental risk indicators.

Statera Biopharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Statera Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Statera Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Statera Biopharma Price Density Drivers

Statera Biopharma Fundamentals Growth

When running Statera Biopharma's price analysis, check to measure Statera Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Statera Biopharma is operating at the current time. Most of Statera Biopharma's value examination focuses on studying past and present price action to predict the probability of Statera Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Statera Biopharma's price. Additionally, you may evaluate how the addition of Statera Biopharma to your portfolios can decrease your overall portfolio volatility.